APA

Breilh D., Djabarouti S., Trimoulet P., Le Bail B., Dupon M., Ragnaud J., Fleury H., Saux M., Thiébaut R., Chêne G. & Neau D. (20091117). Ribavirin plasma concentration predicts sustained virological response to peginterferon Alfa 2a plus ribavirin in previously treated HCV-HIV-coinfected patients. : Journal of acquired immune deficiency syndromes (1999).

Chicago

Breilh Dominique, Djabarouti Sarah, Trimoulet Pascale, Le Bail Brigitte, Dupon Michel, Ragnaud Jean-Marie, Fleury Hervé, Saux Marie-Claude, Thiébaut Rodolphe, Chêne Geneviève and Neau Didier. 20091117. Ribavirin plasma concentration predicts sustained virological response to peginterferon Alfa 2a plus ribavirin in previously treated HCV-HIV-coinfected patients. : Journal of acquired immune deficiency syndromes (1999).

Harvard

Breilh D., Djabarouti S., Trimoulet P., Le Bail B., Dupon M., Ragnaud J., Fleury H., Saux M., Thiébaut R., Chêne G. and Neau D. (20091117). Ribavirin plasma concentration predicts sustained virological response to peginterferon Alfa 2a plus ribavirin in previously treated HCV-HIV-coinfected patients. : Journal of acquired immune deficiency syndromes (1999).

MLA

Breilh Dominique, Djabarouti Sarah, Trimoulet Pascale, Le Bail Brigitte, Dupon Michel, Ragnaud Jean-Marie, Fleury Hervé, Saux Marie-Claude, Thiébaut Rodolphe, Chêne Geneviève and Neau Didier. Ribavirin plasma concentration predicts sustained virological response to peginterferon Alfa 2a plus ribavirin in previously treated HCV-HIV-coinfected patients. : Journal of acquired immune deficiency syndromes (1999). 20091117.